| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From The First Department of Internal Medicine,*
Shinshu
University School of Medicine, Matsumoto, and the Department of
Respiratory Medicine,
Graduate School of
Medicine, Kyoto University, Kyoto, Japan
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Alveolar type II epithelial cells synthesize and secrete surfactant,
control the volume and composition of the epithelial lining fluid,
proliferate, and differentiate into type I alveolar epithelial cells
after lung injury to maintain the integrity of the alveolar
walls.10
Lately they have been recognized to play a role in
regulating the lung immune environment. It is reported that delipidated
surfactant protein markedly augments the migration of alveolar
macrophages in response to endotoxin-activated serum and that
surfactant protein A expresses chemotactic activity for the
monocytes.11,12
Furthermore, the type II epithelial-like
cell line, A549 cells, release monocyte chemoattractant activity (MCA)
constitutively13
and express interleukin (IL)-8 and
monocyte chemoattractant protein (MCP)-1 in response to asbestos, tumor
necrosis factor (TNF)-
, and IL-1ß.14-16
These
cytokines have the potential to attract and activate inflammatory
cells, leading to lung injury.
Cigarette smoke contains more than 4000 chemicals.17 Among them, nicotine, one of the major components of cigarettes, is a chemotactic factor for neutrophils, and acrolein, one of the metabolites of cigarette smoking, stimulates the airway epithelial cells to release lipoxygenase products as neutrophil chemotactic factor (NCA).18,19 Hunninghake and co-workers reported that smoke stimulates the alveolar macrophages to release NCA.3 Kew et al have demonstrated that smoke extract can activate complements.20 Robbins et al have shown that smoke activates the NCA of serum and inhibits the activity of chemotactic factor inactivator.21 However, the possibility that the alveolar type II epithelial cells could interact with cigarette smoke to release the chemotactic activity remains to be elucidated.
Because neutrophils and monocytes play important roles in the pathogenesis of pulmonary emphysema and because type II epithelial cells participate in lung inflammatory responses, we hypothesized that smoke extract might stimulate type II epithelial cells to release NCA and MCA. The results demonstrate that a human alveolar epithelial-like cell line, A549 cells, released NCA and MCA in response to smoke extract, including IL-8, granulocyte colony-stimulating factor (G-CSF), MCP-1, and leukotriene (LT)B4.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Because of difficulty in obtaining primary human type II epithelial cells of sufficient purity, A549 cells (passage 75; American Type Culture Collection, Rockville, MD), a pulmonary type II epithelial cell line derived from an individual with alveolar cell carcinoma, was used.22 These cells retain many of the characteristics of the normal type II epithelial cells, such as surfactant production, cytoplasmic multilamellar inclusion bodies, and cuboidal appearance.16 A549 cells were grown as monolayers on 100-mm-diameter tissue culture dishes. A549 cells were incubated in 100% humidity and 5% CO2 at 37°C with F-12 medium (GIBCO, Grand Island, NY) supplemented with penicillin (50 U/ml; GIBCO), streptomycin (50 µg/ml; GIBCO), fungizone (2 µg/ml; GIBCO), and 10% heat-inactivated fetal calf serum (FCS; GIBCO). The cells from monolayers were harvested with trypsin (0.25%) and EDTA (0.1%) in PBS (Sigma Chemical Co., St. Louis, MO), centrifuged at low speed (250 x g for 5 minutes), and resuspended in fresh medium at the concentration of 1.0 x 106 cells/ml in 35-mm-diameter tissue culture dishes. The cells were grown to confluence during 5 to 7 days of incubation. After the cells reached confluence, the cells were used for the experiment.
Preparation of Cigarette Smoke Extract
Smoke extract was prepared by a modification of the method of Carp and Janoff.8 Briefly, two cigarettes without filters were combusted with a modified syringe-driven apparatus. The smoke was bubbled through 50 ml of Hanks' balanced salt solution (HBSS; GIBCO). The resulting suspension was adjusted to pH 7.4 with concentrated NaOH and then filtered through a 0.20-µm pore filter (Lida Manufacturing Corp., Kenosha, WI) to remove bacteria and large particles. The resulting smoke extract was applied to A549 cell cultures within 30 minutes of preparation.
Exposure of A549 Cells to Smoke Extract
A549 cells were washed twice with serum-free F-12, and the cells were incubated in the presence and absence of smoke extract. To determine the dose- and time-dependent release of NCA and MCA, the cultures were incubated at various concentrations of smoke extract (0%, 0.5%, 1%, 5%, and 10%) for 12, 24, 48, 72, and 96 hours at 37°C in a humidified 5% CO2 atmosphere. Smoke extract did not cause A549 cell injury (no deformity of cell shape and no detachment from tissue culture dish, and greater than 95% of cells were viable by trypan blue exclusion) after 96 hours of incubation at the maximal doses. The supernatant fluids were harvested and stored at -80°C until assayed. At least six separate A549 cell supernatant fluids were harvested from cultures for each experimental condition.
Measurement of NCA and MCA
Polymorphonuclear leukocytes were purified from heparinized normal human blood by the method of Boyum.23 Briefly, 15 ml of venous blood was obtained from healthy volunteers and then sedimented with 3% dextran in isotonic saline for 45 minutes to separate white blood cells from red blood cells. The leukocyte-rich upper layer was collected, and neutrophils were separated from mononuclear cells by Ficoll-Hypaque density centrifugation (Histopaque 1077, Sigma). The contaminating red blood cells were removed by lysing solution with 0.1% KHCO3 and 0.83% NH4Cl. The suspension was then centrifuged at 400 x g for 5 minutes and washed three times in HBSS. The resulting cell pellet consisted of >96% neutrophils and >98% viable cells as determined by trypan blue and erythrosin exclusion. The cells were suspended in Gey's balanced salt solution (GIBCO) containing 2% bovine serum albumin (BSA; Sigma) at pH 7.2 to give a final concentration of 3.0 x 106 cells/ml. This suspension was used for the neutrophil chemotaxis assay.
Mononuclear cells for the chemotaxis assay were obtained from normal
human volunteers by Ficoll-Hypaque density centrifugation to separate
the red blood cells and neutrophils from the mononuclear cells. The
mononuclear cells were harvested at the interface. The suspension was
then centrifuged at 400 x g for 10 minutes and washed
three times in HBSS. The preparation routinely consisted of 30% large
monocytes and 70% small lymphocytes determined by morphology and
-naphthyl acetate esterase staining (Sigma) with >98% viability as
assessed by trypan blue and erythrosin exclusion. The cells were
suspended in Gey's balanced salt solution containing 2% BSA at pH 7.2
to give a final concentration of 5.0 x 106
cells/ml.
This suspension was then used for the monocyte chemotaxis assay.
The chemotaxis assay was performed in a 48-well microchemotaxis chamber (NeuroProbe, Cabin John, MD) as previously described.24 The bottom wells of the chamber were filled with 25 µl of fluid containing the chemotactic stimulus or media in duplicate. A 10-µm-thick polyvinylpyrrolidone-free polycarbonate filter, with a pore size of 3 µm for the neutrophil chemotaxis and 5 µm for the monocyte chemotaxis, was placed over the bottom wells. The silicon gasket and upper pieces of the chamber were applied, and 50 µl of the cell suspension was placed into the upper wells above the filter. The chambers were incubated in humidified air in 5% CO2 at 37°C for 30 minutes for the neutrophil chemotaxis and 90 minutes for the monocyte chemotaxis. Nonmigrated cells were wiped away from the filter. The filter was then immersed in methanol for 5 minutes, stained with Diff-Quik, and mounted on a glass slide. The cells that completely migrated through the filter were counted using light microscopy in 10 random high-power fields (HPF, x1000) per well.
To ensure that monocytes, but not lymphocytes, were the primary cells
that migrated in the monocyte chemotaxis assay, some membranes were
stained with -naphthyl acetate esterase according to the
manufacturer's directions (Sigma).
To determine whether the migration was due to movement along a concentration gradient (chemotaxis) or stimulation of random migration (chemokinesis), a checkerboard analysis was performed with A549 cell supernatant fluid harvested at 72 hours in response to 5% smoke extract.25 To do this, various dilutions of A549 cell supernatant fluids (1:1, 1:4, 1:16, 1:64, and 1:256) were placed below the membrane and above the membrane with target cells.
Partial Characterization of NCA and MCA
Partial characterization of NCA and MCA released from A549 cells was performed with the supernatant fluids harvested after a 72-hour incubation with 5% smoke extract. Sensitivity to proteases was tested by incubating the supernatant fluids with trypsin (100 µg/ml; Sigma) for 30 minutes at 37°C followed by the addition of a 1.5 mol/L excess of soybean trypsin inhibitor to terminate the proteolytic activity, and then the chemotactic activity was evaluated. The lipid solubility was evaluated by mixing the supernatant fluids twice with ethyl acetate, decanting the lipid phase after each extraction, evaporating the ethyl acetate to dryness, and resuspending the extracted material in F-12 used for the cell culture before the chemotaxis assay. Both the extracted and extractant materials were evaluated for chemotactic activity. Heat sensitivity was determined by heating the supernatant fluids at 98°C for 15 minutes.
Molecular Sieve Column Chromatographic Findings of NCA and MCA
To determine the approximate molecular weight of the released activity in the supernatant fluids harvested at 72 hours in response to 5% smoke extract, molecular sieve column chromatography was performed using Sephadex G-200 (Pharmacia, Piscataway, NJ). At a flow rate of 6 ml/hour, A549 cell culture supernatant fluid was eluted with PBS, and fractions were evaluated for NCA and MCA in duplicate.
Effects of Metabolic Inhibitors on the Release of NCA and MCA
The effects of nonspecific lipoxygenase inhibitors, nordihydroguaiaretic acid (NDGA, 100 µmol/L; Sigma), diethylcarbamazine (DEC, 1 mmol/L; Sigma), and 5-lipoxygenase inhibitor AA-861 (100 µmol/L; Takeda Pharmaceutical Co., Tokyo, Japan) on the release of NCA and MCA in response to 5% smoke extract for a 72-hour incubation were evaluated. To further examine the involvement of protein synthesis in the release of the chemotactic activity, cycloheximide (20 µg/ml; Sigma) was added to inhibit protein synthesis.26
Effects of LTB4 and PAF Receptor Antagonists on NCA and MCA
Because the release of NCA and MCA was blocked by 5-lipoxygenase inhibitors, and because NCA and MCA were extracted into ethyl acetate, LTB4 receptor antagonist (ONO 4057, ONO Pharmaceutical Co., Tokyo, Japan) and platelet-activating factor (PAF) receptor antagonist (TCV 309, Takeda Pharmaceutical Co.) at the concentration of 10-5 mol/L were used to evaluate the involvement of LTB4 and PAF for NCA and MCA.27,28
Measurement of LTB4 and PAF in the Supernatant Fluid
The concentration of LTB4 in the supernatants was measured by radioimmunoassay (RIA) as previously described.29-31 Anti-LTB4 serum, [5,6,8,9,11,12,14,15,3H(N)]-LTB4, and synthetic LTB4 were purchased from Amersham Co. (Arlington Heights, IL). Briefly, ethanol and supernatant mixtures were centrifuged at 5500 x g at 0°C. At a temperature of 37°C, the supernatants were evaporated under N2 gas to remove ethanol. To each sample, 10 ml of distilled water was added. These samples were acidified to pH 4.0 with 0.1 mol/L hydrochloric acid and applied to Sep-Pak C l8 columns (Waters Associates, Milford, MA). The columns were washed with a 10-ml mixture of distilled water and 20 ml of petroleum ether and then eluted with 15 ml of methanol. These eluates were dried with N2 gas at 37°C and then redissolved in 20 µl of methanol and 180 µl of RIA buffer (50 mmol/L Tris/HCl buffer containing 0.1% (w/v) gelatin, pH 8.6). [3H]LTB4 was diluted in RIA buffer (100 µl, containing approximately 4000 dpm) and mixed with 100 µl of standards or samples in disposable siliconized tubes. Anti-LTB4 serum, diluted by RIA buffer (100 µl), was added to siliconized tubes to give a total incubation volume of 400 µl. The mixture was incubated at 4°C for 18 hours. Free LTB4 was absorbed onto dextran-coated charcoal. The supernatant, containing the antibody-bound LTB4 was decanted into scintillation counter after centrifugation for 15 minutes at 2000 x g. Scintillation fluid (Aquazol 2, NEN Co., Boston, MA) was added, and radioactivity was counted by a scintillation counter (Tricarb-3255, Tackard Co., IL) for 4 minutes.
PAF in the supernatant fluids was evaluated via the scintillation proximity assay system. Briefly, this assay system combined the use of a high-specific-activity tritiated PAF tracer with an antibody specific for PAF and a PAF standard similar to the methods of measurement of LTB4.
Effects of Polyclonal Antibodies to IL-8, G-CSF, MCP-1, GM-CSF, RANTES, and TGF-ß
The neutralizing antibodies to human IL-8, G-CSF, MCP-1, RANTES (regulated on activation, normal T cells, expressed and secreted), granulocyte-macrophage colony-stimulating factor (GM-CSF), and transforming growth factor (TGF)-ß were purchased from Genzyme (Cambridge, MA). They were added to the A549 cell supernatant fluids that were harvested at 72 hours in response to 5% smoke extract at the suggested concentration to inhibit these cytokines and incubated for 30 minutes at 37°C. To evaluate the nonspecific effect of IgG, nonimmune IgG was added to the same supernatant fluids and incubated for 30 minutes at 37°C. These samples were then used for the chemotactic assay. These antibodies did not influence the chemotactic response to endotoxin-activated serum (data not shown).
Measurement of IL-8, G-CSF, MCP-1, GM-CSF, RANTES, and TGF-ß in the Supernatant Fluids
The concentrations of IL-8, G-CSF, MCP-1, GM-CSF, RANTES, and TGF-ß in A549 cell supernatant fluids cultured for 72 hours in response to 5% smoke extract were measured by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's directions. GM-CSF and RANTES kits were purchased from Amersham (Little Chalfont, UK), and the minimal concentration detected by these methods was 2.00 pg/ml for GM-CSF and 15.6 pg/ml for RANTES. IL-8, MCP-1, and TGF-ß kits were purchased from R&D Systems (Minneapolis, MN), and the minimal detectable concentration of IL-8, MCP-1, and TGF-ß was 10.0, 31.3, and 310 pg/ml, respectively. The G-CSF kit was obtained from Chugai Pharmaceutical Co., Tokyo, Japan. The minimal concentration of G-CSF detected by this kit was 1.0 pg/ml.
Statistics
In experiments where multiple measurements were made, differences between groups were tested for significance using one-way analysis of variance with Duncan's multiple range test applied to data at specific time and dose points. In experiments where a single measurement was made, the differences between groups were tested for significance using Student's paired t-test. In all cases, a P value less than 0.05 was considered significant. The data in the figures and tables are expressed as means ± SEM.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In response to smoke extract, A549 cells released NCA and MCA in a
dose-dependent manner (P < 0.05; Figure 1, A and B
). The lowest doses of smoke
extract to stimulate A549 cells were 0.5% for neutrophils and 1% for
monocytes. Increasing concentrations of smoke extract progressively
increased the release of chemotactic activity up to 10%. A549 cells
released NCA and MCA in response to smoke extract in a time-dependent
manner (P < 0.05; Figure 2, A and B
). After the exposure to smoke
extract, the release of NCA and MCA was significant after 48 hours
(P < 0.05; Figure 2, A and B
). Smoke extract
itself was not chemotactic for neutrophils and monocytes (data not
shown).
|
|
Checkerboard analysis revealed that the A549 cell supernatant fluids
stimulated by smoke extract induced neutrophil and monocyte migration
in the presence of a gradient across the membrane in a
concentration-dependent manner. However, a smaller increase of the
neutrophil and monocyte migration was observed in the absence of a
gradient (Table 1)
. Thus, the migration
of neutrophils and monocytes was predominantly consistent with
chemotactic rather than chemokinetic activity.
|
Partial Characterization of NCA and MCA
The NCA and MCA were heterogeneous in character. Both NCA and MCA
were partially but significantly sensitive to heat, extractable into
ethyl acetate, and partially digested by trypsin (Figure 3, A and B)
.
|
The released chemotactic activity of the supernatant fluids was
evaluated by molecular sieve column chromatography using Sephadex
G-200. These experiments revealed that NCA obtained from the
unstimulated cells was heterogeneous in size (Figure 4A)
. At least three peaks of activity
were separated by column chromatography with two peaks near cytochrome
c (molecular weight, 12,300) and an additional peak that eluted near
quinacrine (molecular weight, 450). By stimulation of smoke extract,
these peaks became prominent.
|
.
At least three peaks of activity were separated by column
chromatography with two peaks between BSA and cytochrome c, and an
additional peak eluted near quinacrine. When stimulated with smoke
extract, each peak became prominent. Effects of Metabolic Inhibitors on the Release of NCA and MCA
The 72-hour supernatant fluids incubated with 5% smoke extract in
the presence of NDGA, DEC, and AA-861 showed a significant decrease in
the release of NCA and MCA. Cycloheximide also inhibited the release of
NCA and MCA (P < 0.05; Figure 5, A and B
).
|
NCA and MCA in the supernatant fluids were significantly inhibited
by the addition of LTB4 receptor antagonist ONO4057,
approximately 50% for NCA and 40% for MCA (Figure 6, A and B)
. ONO4057 also inhibited the
chromatography-separated lowest molecular weight peak more than 80%
for both NCA and MCA (data not shown). The effects of PAF receptor
antagonist TCV 309 on chemotactic activity were not significant for NCA
and MCA. Each receptor antagonist at the concentration of
10-5 mol/L completely inhibited the neutrophil migration
in response to 10-7 mol/L LTB4 and PAF,
respectively, but showed no inhibitory effects on
activated-serum-induced neutrophil and monocyte chemotaxis (data not
shown).
|
The measurement of LTB4 by RIA revealed
that A549 cells released LTB4 in the baseline culture
condition. The addition of smoke extract at the concentration of 5%
for 72 hours induced a significant increase in LTB4 release
from A549 cells (P > 0.05; Figure 7
). In contrast, PAF was not detected in
the baseline and smoke-extract-stimulated supernatant fluids.
|
We evaluated the capacity of polyclonal blocking antibodies to
IL-8, G-CSF, MCP-1, GM-CSF, RANTES, or TGF-ß to reduce NCA and MCA.
Anti-IL-8 and G-CSF antibodies significantly blocked NCA. Anti-MCP-1
antibody significantly reduced MCA (Figure 8)
. Nonimmune IgG did not have any
effects on NCA and MCA. We evaluated the effects of IL-8, G-CSF, and
MCP-1 antibodies on the column-chromatography-separated
high-molecular-weight peaks. These antibodies inhibited the chemotactic
activity at the corresponding molecular weight peak (data not shown).
|
The measurement of chemokines by ELISA revealed that A549 cells
released IL-8, G-CSF, MCP-1, and TGF-ß constitutively. Smoke extract
stimulated the release of IL-8 G-CSF, and MCP-1 significantly (Figures 9, A and B, and 10A)
, but smoke extract
did not stimulate the release of TGF-ß (Figure 10B)
. GM-CSF and RANTES were not
detected in the A549 cell supernatant fluids.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
It is recognized that destruction of the alveolar structures requires enzymes with elastolytic activity. A large amount of evidence suggests that neutrophils are the source of this elastolytic activity. Although a monocyte contains approximately 3% of elastase compared with a neutrophil, it is recently reported that the macrophage elastase is sufficient for the development of pulmonary emphysema. Macrophage elastase-deficient mice did not develop emphysema after chronic inhalation of cigarette smoke.6 Thus, both the neutrophil and the monocyte may contribute to the etiology of pulmonary emphysema in cigarette smokers.
The type II alveolar epithelial cells had been regarded as passive
bystanders in the immune interactions. However, previous studies have
shown that A549 cells can release soluble chemotactic factors that
direct the migration of neutrophils and monocytes into the alveolar
space in response to TNF- and IL-1ß.14,16
Koyama et al
have reported that A549 cells released chemoattractant activity for
monocytes spontaneously.13
The present study demonstrated
that A549 cells can also release NCA and MCA in response to smoke
extract and suggested the possibility that the type II alveolar
epithelial cells play a role in defining the lung inflammatory
environment.
The present study demonstrates that several chemotactic factors were released by A549 cells that may contribute to the inflammatory cell recruitment. Partial characterization revealed that the released NCA and MCA were partly ethyl acetate extractable. Pretreatment with AA-861, NDGA, and DEC inhibited the release of NCA and MCA. Molecular sieve column chromatography showed that there was a large chemotactic peak in the lowest molecular range. The chemotactic activity in the lowest molecular peak was inhibited by LTB4 receptor antagonist. Furthermore, the concentration of LTB4 assessed by RIA is high enough to produce neutrophil and monocyte chemotactic activity. Smoke extract increased the release of LTB4 into A549 cell culture supernatant fluids. In this context, LTB4 may be the predominant chemotactic activity.
In contrast, the trypsin sensitivity of the chemotactic activity along with the inhibition of the release by cycloheximide suggests that the activity was at least partly dependent on protein synthesis. Molecular sieve column chromatography revealed increases in the high molecular weight peaks of chemotactic activity in response to smoke extract. The antibodies to IL-8, G-CSF, and MCP-1 inhibited the NCA and MCA. IL-8, G-CSF, and MCP-1 were significantly increased in the supernatant fluid in response to smoke extract. These concentrations of IL-8, G-CSF and MCP-1 were chemotactic for neutrophils and monocytes, respectively. These data suggest that these cytokines may play important roles in the recruitment of inflammatory cells into the lungs of smokers.
Early descriptions of cytokines focused on their production by immune and inflammatory effector cells. However, it is apparent that structural cells are also capable of releasing many cytokines. A549 cells are known to produce a variety of cytokines, including IL-8,14,15 G-CSF,34 TGF-ß,13 and MCP-1,16 in response to a variety of stimuli. However, the relation between smoking and the release of these cytokines has not been established. The present study demonstrated that A549 cells released these cytokines as chemotactic factors in response to smoke extract and suggest that these cytokines may play a role in smoking-induced lung disease by recruiting inflammatory cells.
Although TGF-ß was detected in the supernatant fluid, TGF-ß antibody did not attenuate monocyte chemotactic activity. TGF-ß induces monocyte chemotaxis at concentrations from 0.1 to 10 pg/ml.35 At higher concentration, the chemotactic response of monocytes declines. It was reported that the biologically inactive form of TGF-ß, which constitutes more than 98% of autocrine TGF-ß, is secreted by 12 different cell types. TGF-ß was unable to bind to the receptor without previous proteolytic activation.36 The release of inactive TGF-ß may account for the lack of inhibition of MCA in the A549 cell supernatant fluids by anti-TGF-ß..
G-CSF could be an important factor determining the number and functional activity of neutrophils. G-CSF has been reported to induce neutrophil migration at concentrations of more than 10 to 100 U/ml (7 to 10 ng/ml).37 The concentration of G-CSF in the supernatant fluids released from A549 cells was relatively low in the present study. However, the blocking antibody of G-CSF inhibited chemotactic response of neutrophils up to 46%. Recently, we have found that doses of 10 to 100 pg/ml G-CSF will induce significant NCA.34 Although G-CSF may be facilitating the chemotactic response of other cytokines, the concentration of G-CSF in the culture supernatant fluids exceeded the lower chemotactic threshold observed in our laboratory.
In conclusion, A549 cells released chemotactic activity toward neutrophils and monocytes in response to cigarette smoke extract. The released activity was lipid and peptide in its nature and involved LTB4, IL-8, G-CSF, and MCP-1. These data suggest the possibility that the type II alveolar epithelial cells may play an important role in the recruitment of the inflammatory cells in the lung in response to cigarette smoke.
|
Footnotes |
|---|
Accepted for publication August 31, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  R. L. Rouse, G. Murphy, M. J. Boudreaux, D. B. Paulsen, and A. L. Penn Soot Nanoparticles Promote Biotransformation, Oxidative Stress, and Inflammation in Murine Lungs Am. J. Respir. Cell Mol. Biol., August 1, 2008; 39(2): 198 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Chung and I. M. Adcock Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Facchinetti, F. Amadei, P. Geppetti, F. Tarantini, C. Di Serio, A. Dragotto, P. M. Gigli, S. Catinella, M. Civelli, and R. Patacchini {alpha},beta-Unsaturated Aldehydes in Cigarette Smoke Release Inflammatory Mediators from Human Macrophages Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 617 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Thatcher, S. B. Maggirwar, C. J. Baglole, H. F. Lakatos, T. A. Gasiewicz, R. P. Phipps, and P. J. Sime Aryl Hydrocarbon Receptor-Deficient Mice Develop Heightened Inflammatory Responses to Cigarette Smoke and Endotoxin Associated with Rapid Loss of the Nuclear Factor-{kappa}B Component RelB Am. J. Pathol., March 1, 2007; 170(3): 855 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Thirkill, H. Vedagiri, and G. C. Douglas Macaque Trophoblast Migration toward RANTES Is Inhibited by Cigarette Smoke-Conditioned Medium Toxicol. Sci., June 1, 2006; 91(2): 557 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Meyer, L. D. Dwyer-Nield, G. Hurteau, R. L. Keith, Y. Ouyang, B. M. Freed, L. R. Kisley, M. W. Geraci, J. V. Bonventre, R. A. Nemenoff, et al. Attenuation of the pulmonary inflammatory response following butylated hydroxytoluene treatment of cytosolic phospholipase A2 null mice Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1260 - L1266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Berrahmoune, J. V. Lamont, B. Herbeth, P. S. FitzGerald, and S. Visvikis-Siest Biological Determinants of and Reference Values for Plasma Interleukin-8, Monocyte Chemoattractant Protein-1, Epidermal Growth Factor, and Vascular Endothelial Growth Factor: Results from the STANISLAS Cohort Clin. Chem., March 1, 2006; 52(3): 504 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shinkai, G. H. Foster, and B. K. Rubin Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L75 - L85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Chung The Role of Airway Smooth Muscle in the Pathogenesis of Airway Wall Remodeling in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 347 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Thatcher, N. A. McHugh, R. W. Egan, R. W. Chapman, J. A. Hey, C. K. Turner, M. R. Redonnet, K. E. Seweryniak, P. J. Sime, and R. P. Phipps Role of CXCR2 in cigarette smoke-induced lung inflammation Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L322 - L328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhang, P. Adiseshaiah, and S. P. Reddy Matrix Metalloproteinase/Epidermal Growth Factor Receptor/Mitogen-Activated Protein Kinase Signaling Regulate fra-1 Induction by Cigarette Smoke in Lung Epithelial Cells Am. J. Respir. Cell Mol. Biol., January 1, 2005; 32(1): 72 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Laan, S. Bozinovski, and G. P. Anderson Cigarette Smoke Inhibits Lipopolysaccharide-Induced Production of Inflammatory Cytokines by Suppressing the Activation of Activator Protein-1 in Bronchial Epithelial Cells J. Immunol., September 15, 2004; 173(6): 4164 - 4170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. R. Witherden, E. J. Vanden Bon, P. Goldstraw, C. Ratcliffe, U. Pastorino, and T. D. Tetley Primary Human Alveolar Type II Epithelial Cell Chemokine Release: Effects of Cigarette Smoke and Neutrophil Elastase Am. J. Respir. Cell Mol. Biol., April 1, 2004; 30(4): 500 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Koch, M. Giembycz, K. Ito, S. Lim, E. Jazrawi, P. J. Barnes, I. Adcock, E. Erdmann, and K. F. Chung Mitogen-Activated Protein Kinase Modulation of Nuclear Factor-{kappa}B-Induced Granulocyte Macrophage-Colony-Stimulating Factor Release from Human Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 342 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E-J.D. Oudijk, J-W.J. Lammers, and L. Koenderman Systemic inflammation in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 5S - 13s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Churg, R. D. Wang, H. Tai, X. Wang, C. Xie, J. Dai, S. D. Shapiro, and J. L. Wright Macrophage Metalloelastase Mediates Acute Cigarette Smoke-induced Inflammation via Tumor Necrosis Factor-{alpha} Release Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1083 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Koyama, E. Sato, A. Tsukadaira, M. Haniuda, H. Numanami, M. Kurai, S. Nagai, and T. Izumi Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro Eur. Respir. J., December 1, 2002; 20(6): 1449 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. K. Russell, A. Thorley, S. V. Culpitt, S. Dodd, L. E. Donnelly, C. Demattos, M. Fitzgerald, and P. J. Barnes Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L867 - L873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Churg, K. Zay, S. Shay, C. Xie, S. D. Shapiro, R. Hendricks, and J. L Wright Acute Cigarette Smoke-Induced Connective Tissue Breakdown Requires both Neutrophils and Macrophage Metalloelastase in Mice Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 368 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Christofidou-Solomidou, S. Kennel, A. Scherpereel, R. Wiewrodt, C. C. Solomides, G. G. Pietra, J.-C. Murciano, S. A. Shah, H. Ischiropoulos, S. M. Albelda, et al. Vascular Immunotargeting of Glucose Oxidase to the Endothelial Antigens Induces Distinct Forms of Oxidant Acute Lung Injury : Targeting to Thrombomodulin, But Not to PECAM-1, Causes Pulmonary Thrombosis and Neutrophil Transmigration Am. J. Pathol., March 1, 2002; 160(3): 1155 - 1169. [Abstract] [Full Text] [PDF]
|
, chemotactic activity
stimulated by smoke extract; 
, chemotactic activity without smoke
extract. *P < 0.05 compared with F-12 medium;
**P < 0.05 compared with the supernatant fluids without smoke
extract.
